Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 6 results
Author
Title
Type
Year
Filters:
Author
is
Chinnaiyan, Arul M
[Clear All Filters]
2018
Armenia J
,
Wankowicz SAM
,
Liu D
,
Gao J
,
Kundra R
,
Reznik E
,
Chatila WK
,
Chakravarty D
,
G Han C
,
Coleman I
et al.
. 2018.
The long tail of oncogenic drivers in prostate cancer.
.
Nat Genet. 50(5):645-651.
2015
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
2014
Park K
,
Chen Z
,
MacDonald TY
,
Siddiqui J
,
Ye H
,
Erbersdobler A
,
Shevchuk MM
,
Robinson BD
,
Sanda MG
,
Chinnaiyan AM
et al.
. 2014.
Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.
.
Hum Pathol. 45(10):2136-43.
2012
Lapuk AV
,
Wu C
,
Wyatt AW
,
McPherson A
,
McConeghy BJ
,
Brahmbhatt S
,
Mo F
,
Zoubeidi A
,
Anderson S
,
Bell RH
et al.
. 2012.
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.
.
J Pathol. 227(3):286-97.
Demichelis F
,
Setlur SR
,
Banerjee S
,
Chakravarty D
,
Chen JYun Helen
,
Chen CX
,
Huang J
,
Beltran H
,
Oldridge DA
,
Kitabayashi N
et al.
. 2012.
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
.
Proc Natl Acad Sci U S A. 109(17):6686-91.
Collins CC
,
Volik SV
,
Lapuk AV
,
Wang Y
,
Gout PW
,
Wu C
,
Xue H
,
Cheng H
,
Haegert A
,
Bell RH
et al.
. 2012.
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
.
Mol Cancer Ther. 11(3):775-83.